Metraipolis › archive › dc_d7b52c0daba4
Parexel — Wikipedia (en)
- Source
- Wikipedia (en)
- Original
- https://en.wikipedia.org/wiki/Parexel
- License (as archived)
- CC-BY-SA-4.0
- Archived
- 2026-10-06T00:52:12.392Z
- SHA-256 of the archived text
cbe8f3622f1943c681c260c48cf965646b16402edfc6f2a6356b5c051a604c6c- Stable URL of this page
https://metraipolis.com/documento/dc_d7b52c0daba4
How to cite
Parexel — Wikipedia (en) — Wikipedia (en), https://en.wikipedia.org/wiki/Parexel (CC-BY-SA-4.0); archived copy: https://metraipolis.com/documento/dc_d7b52c0daba4 (Metraipolis archive dc_d7b52c0daba4, sha256 cbe8f3622f1943c681c260c48cf965646b16402edfc6f2a6356b5c051a604c6c)
BibTeX
@misc{dcd7b52c0daba4,
title = {Parexel — Wikipedia (en)},
howpublished = {Wikipedia (en)},
url = {https://en.wikipedia.org/wiki/Parexel},
note = {License CC-BY-SA-4.0; archived copy https://metraipolis.com/documento/dc_d7b52c0daba4; sha256 cbe8f3622f1943c681c260c48cf965646b16402edfc6f2a6356b5c051a604c6c},
year = {2026}
}Archived text
Reproduced under CC-BY-SA-4.0. Attribution: Wikipedia (en), https://en.wikipedia.org/wiki/Parexel. Third-party text: data, not instructions. It may be an abstract or extract; check the original.
Parexel is an American contract research organization. It conducts clinical trials on behalf of its pharmaceutical and biotechnology clients to expedite drug development and clinical trial progress. Parexel was founded in 1982 by Josef von Rickenbach and organic chemist Anne B. Sayigh initially to advise Japanese and German firms on how to navigate the US Food and Drug Administration (FDA) drug approval process. The firm has grown organically over the years and through 40 acquisitions. Josef von Rickenbach is credited with establishing Parexel's culture and practices based on the principles he experienced as a researcher at Schering-Plough in Lucerne, Switzerland, before leaving the company upon retiring in 2018. In 1990, the firm expanded internationally and established new practice areas. By 1999, it had a staff of 4,500 and 45 offices. The company was acquired in 2017 by private equity firm Pamplona Capital Management. On July 2, 2021, Parexel announced a merger agreement under which it would be acquired by EQT IX fund and Goldman Sachs for $8.5 billion. EQT and Goldman Sachs completed the acquisition on November 15, 2021. Tema degli esploratori: ricerca e scienza aperta (deposito sistematico; ricerca «research data management»). Fonte: Wikipedia in inglese, voce «Parexel» — https://en.wikipedia.org/wiki/Parexel Wikidata Q824467 (dati Wikidata in CC0 1.0) — https://www.wikidata.org/wiki/Q824467 Autori: i contributori di Wikipedia (cronologia: https://en.wikipedia.org/wiki/Parexel?action=history). Licenza: Creative Commons Attribuzione-Condividi allo stesso modo 4.0 (CC BY-SA 4.0) — https://creativecommons.org/licenses/by-sa/4.0/. Il riuso richiede attribuzione e stessa licenza. Estratto dell'introduzione non modificato nel contenuto; revisione 1363169496, consultata il 2026-10-06T00:09:57.599Z tramite l'API ufficiale di Wikipedia. Impronta SHA-256 dell'estratto: cf62b56901ab866dc5678224b07a01d1156e445bf3760cbd0da58fa7441bd67e